BRWA
BNGO icon

B. Riley Wealth Advisors’s Bionano Genomics BNGO Stock Holding History

B. Riley Wealth Advisors’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-24
Closed -$20K – 1461
2022
Q2 		$20K Hold
24
– – ﹤0.01% 1201
2022
Q1 		$37K Sell
24
-15
-38% -$20.2K ﹤0.01% 1345
2021
Q4 		$71K Buy
+39
New +$104K ﹤0.01% 1359
2021
Q3 		– Sell
-19
Closed -$86K – 1417
2021
Q2 		$86K Buy
+19
New +$75K ﹤0.01% 1322

Other funds holding BNGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $149B AUM 24.71% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

B. Riley Wealth Advisors's BNGO Position: Q3 2022 in Review

B. Riley Wealth Advisors sold out of Bionano Genomics (BNGO) in Q3 2022, closing a stake of 24 shares — an estimated $20K sold.

B. Riley Wealth Advisors first reported a position in BNGO in Q2 2021 and held it in 4 quarters. The position peaked at $86K in Q2 2021. 140 funds tracked by Wall St. Rank hold BNGO as of Q3 2022.

  • B. Riley Wealth Advisors reported no remaining Bionano Genomics position as of Q3 2022 after selling out during the quarter.
  • B. Riley Wealth Advisors sold 24 Bionano Genomics shares in Q3 2022, an estimated $20K.
  • B. Riley Wealth Advisors first reported a position in Bionano Genomics in Q2 2021 and held it in 4 quarters.
  • B. Riley Wealth Advisors's Bionano Genomics position peaked at $86K in Q2 2021.
  • 140 funds tracked by Wall St. Rank held Bionano Genomics as of Q3 2022.

Based on B. Riley Wealth Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.